Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8898363 | 0.91 | ALDH1A1 (0.32) | ALDH1A1FFAR1CPT2TDP1TSHR | |
| SCHEMBL18381432 | 0.91 | SLC22A6 (0.50) | MAPTKMT2AALDH1A1FFAR1TDP1 | |
| SCHEMBL5443034 | 0.87 | FNTA (0.30) | FNTAFNTB | |
| SCHEMBL15457453 | 0.86 | MAPT (0.37) | MAPTKMT2AALDH1A1FFAR1CPT2 | |
| SCHEMBL491385 | 0.85 | KMT2A (0.56) | MAPTKMT2AALDH1A1FFAR1TDP1 | |
| SCHEMBL5705314 | 0.85 | — | — | |
| SCHEMBL8096567 | 0.84 | KMT2A (0.59) | MAPTKMT2AALDH1A1FFAR1TDP1 | |
| SCHEMBL18085816 | 0.84 | KMT2A (0.59) | MAPTKMT2AALDH1A1FFAR1TDP1 | |
| SCHEMBL8897711 | 0.84 | KMT2A (0.59) | MAPTKMT2AALDH1A1FFAR1TDP1 | |
| SCHEMBL25885737 | 0.83 | MAPT (0.41) | MAPTKMT2AALDH1A1FFAR1CPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002030860-A9 | KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS INC (US) | 2003-02-20 | — | — | WO | disclosed |